Market Cap: $1.45M
BI
Beyond Air, Inc.
XAIR
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $1.45M
Connected, modular device design that lowers downtime draws attention from medical device firms such as Beyond Air Modular, connected platforms reshaping device adoption American Pipelining Solutions…
APS rolls out single-head UV curing for small-diameter relining American Pipelining Solutions (APS) is adding the UV XAIR ultraviolet (UV) curing system to its portfolio, bringing single-head, small-d…
Beyond Air Advances Lung Delivery Technology for Respiratory Treatments Beyond Air, a pioneering company in lung-targeted therapies, continues to make strides in its innovative approach to treating re…
Beyond Air's Innovations in Respiratory Therapies: A Focus on Nitric Oxide Delivery Beyond Air is making significant strides in the field of respiratory therapies, particularly through its innovative…
Beyond Air: Advancing Medical Technologies for Respiratory Conditions Beyond Air is poised to release its quarterly earnings on August 12, 2025, as it continues to make strides in the innovative medic…
Innovative Advances in Medical Technologies: Beyond Air's Pioneering Role Beyond Air (XAIR) stands at the cutting edge of medical innovation, particularly in the realm of respiratory treatments utiliz…
Innovative Advances in Respiratory Treatment: Beyond Air's Strategic Focus Beyond Air (XAIR) is a pioneering player in the medical technology sector, specializing in the development of nitric oxide th…
Beyond Air Advances Innovative Lung Delivery System Amid Financial Growth Beyond Air, Inc. announces its fourth-quarter financial results, showcasing a notable increase in revenue attributed to its in…
Beyond Air Advances Nitric Oxide Delivery Systems Amid Positive Financial Trends Beyond Air, Inc. is making significant strides in the field of medical technology with its innovative nitric oxide deli…
Beyond Air's Innovative Approach to Respiratory Treatment Beyond Air, Inc. emphasizes its commitment to revolutionizing the treatment of respiratory diseases through its innovative lung delivery techn…